Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries : policy statement

World Health Organization (2011). Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries : policy statement. World Health Organization.

Title
Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries : policy statement
Authors
World Health Organization
Issued
2011-12-31
Type
book
Publisher
World Health Organization
ISBN
9789241502672
Language
en
Abstract
This policy statement provides evidence-based recommendations on the use of commercial interferon-gamma release assays (IGRAs) for tuberculosis (TB) in low- and middle-income countries, particularly settings with a high TB and/or HIV burden. Based on systematic reviews and GRADE assessment, it evaluates IGRAs for diagnosis of active TB, detection of latent TB infection (LTBI) in children and people living with HIV, screening of health care workers and contacts, outbreak investigations, and prediction of progression to active disease. The evidence was generally of low or very low quality and did not demonstrate superior performance of IGRAs over the tuberculin skin test (TST). WHO recommends that IGRAs and the TST not be used to diagnose active TB or identify individuals at risk of developing active disease, and that IGRAs not replace the TST for LTBI diagnosis in children, people living with HIV, or contacts. Given comparable performance, greater cost and technical complexity, replacing the TST with IGRAs as a public health intervention in resource-constrained settings is not recommended.

Sources

In the knowledge graph

  • IRI references/10665-44759
  • provenance: catalogue
  • read from who-iris/catalogue/records/10665-44759.dc.json (who-iris, sub-graph who-iris-catalogue)
  • library copy: who-iris/library/10665-44759

Export: BibTeX · RIS · CSL-JSON · DC XML

All references of who-iris-catalogue


Reference Architecture and Guidance for Digital Public Infrastructure for the Health Sector — built with folio-assistant.

deployed dev